Recent Finacing
Recent Raise
Cellerix, Madrid-based biopharma, develops adult stem cell therapies including autologous Cx401 for perianal fistulas (Phase III), Cx501 for epidermolysis bullosa (Phase II), and preclinical allogeneic programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
